PUBLICATIONS
LINKS
SPECIAL MEMBERS / SPONSORS
JOIN THE EBC
English
日本語
ABOUT
History & Core Mission
Organisation
EBC Constitution
Regulatory Expertise and Services
FAQ
EBC in the Media
EBO Worldwide Network
COMMITTEES
Business Fundamentals
Financial Services
Transportation & Communications
Health Science
Consumer Goods
Industry
EBC Achievements
Digital White Paper
All Issues
New Issues
Resolved Issues
NEWS
Event
Newsletter
Press Releases
Statements
Survey
CONTACT
HOME
ABOUT
COMMITTEES
SPECIAL MEMBERS / SPONSORS
PUBLICATIONS
JOIN THE EBC
Together towards a more sustainable future
All Issues
New Issues
Resolved Issues
NEWS
LINKS
CONTACT
Issues
ALL
New
Not prioritised
Progress
Resolved
Urgent
Committee:
All
Cross-Committee Issues
Human Resources
Intellectual Property Rights
Legal Services
Retail & Wholesale
Food & Agriculture
Liquor
Asset Management
Insurance
IVD (In Vitro Diagnostics)
Pharmaceuticals
Vaccines
Cosmetics & Quasi-drugs
Medical Equipment
Aeronautics
Automobile
Automotive Components & Aftermarket
Energy
Space
Defence & Security
Airlines
Logistics & Freight
Railways
Telecommunications Equipment
Print
Health Science
Pharmaceuticals
Published:
November 29, 2021
Drug pricing system
status:
Negative progress
